Valuation (29%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.04 | N/A |
| PEG Ratio (TTM) | 0.55 | N/A |
| P/S Ratio (TTM) | 3.92 | N/A |
| P/B Ratio (TTM) | 2.32 | N/A |
| P/FCF Ratio (TTM) | -4.09 | N/A |
| Price to 5YR AVG Earnings Ratio | -4.28 | N/A |
| Price to 5YR AVG FCF Ratio | -5.50 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -32.29% | N/A |
| ROE (TTM) | -41.68% | N/A |
| Net Profit Margin (TTM) | -77.71% | N/A |
| ROIC 5YR AVG | -59.17% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -124.25% | -2,203.67% | -1,324.63% |
| Revenue | -5.47% | -10.48% | -13.84% |
| Net Income | -127.40% | -2,177.36% | -1,309.61% |
| Cash Flow | -19.16% | -157.40% | -99.41% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.85 | N/A |
| Quick Ratio (TTM) | 4.10 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 2.32 | N/A |
| LTL to 5YR AVG FCF | -0.07 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.51% | N/A |